The company specializes in the development of innovative injectables that stabilize spinal disc integrity and repair connective tissues without the need for surgery. Their flagship product, DiscSeal, is a percutaneous injection treatment designed for patients suffering from chronic discogenic lower back pain. DiscSeal serves as an early-stage treatment option for patients who have not responded to conservative care and are not yet eligible for invasive surgical options like total disc replacement or spinal fusion. Founded in 2004 and headquartered in San Diego, California, SpineOvations is led by experienced executives in the life sciences and backed by renowned spinal surgeons and neurosurgeons. Their goal is to provide patients with a cost-effective alternative to back surgery, improving motion and mobility while avoiding the risks and expenses associated with invasive procedures.